Aandelen in “Gezondheidstechnologie”

Aandeel Datum Koers Evolutie
Geen effecten gevonden.

Nieuws over “Gezondheidstechnologie”

22:15 · Danaher Announces Quarterly Dividend · Persbericht

22:15 · Danaher Announces Quarterly Dividend · Persbericht

22:05 · Perimeter Medical Imaging AI Closes C$3.6 Million Non-Brokered Private Placement · Persbericht

22:01 · AMGEN ANNOUNCES 2026 FIRST QUARTER DIVIDEND · Persbericht

22:01 · Neurocrine Biosciences to Host R&D Day on December 16 · Persbericht

21:30 · Lilly to build $6 billion facility to manufacture active pharmaceutical ingredients in Alabama · Persbericht

18:58 · Inspire Medical (INSP) Crashes Over 32%, "Inspire V" Launch Failure, Hagens Berman Urges Investors with Losses to Contact Firm by Jan. 5 · Persbericht

18:00 · EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of November 30, 2025 · Persbericht

18:00 · IPSEN - Buy-back programme - Art 5 of MAR - Week 49- 2025 · Persbericht

17:57 · Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions · Persbericht

17:57 · Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions · Persbericht

15:00 · Investors who lost money on Baxter International, Inc.(BAX) should contact Levi & Korsinsky about pending Class Action - BAX · Persbericht

15:00 · Shareholders that lost money on DexCom, Inc.(DXCM) should contact Levi & Korsinsky about pending Class Action - DXCM · Persbericht

15:00 · Class Action Filed Against Perrigo Company plc (PRGO) Seeking Recovery for Investors - Contact Levi & Korsinsky · Persbericht

15:00 · Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025 · Persbericht

15:00 · Shareholders that lost money on Inspire Medical Systems, Inc.(INSP) should contact Levi & Korsinsky about pending Class Action - INSP · Persbericht

14:51 · Novo Nordisk has completed its acquisition of Akero Therapeutics · Persbericht

14:30 · Citius Oncology Announces $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules · Persbericht

14:28 · Lilly and Adverum announce expiration and completion of Adverum tender offer and acquisition · Persbericht

14:28 · Lilly and Adverum announce expiration and completion of Adverum tender offer and acquisition · Persbericht

14:01 · Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection · Persbericht

Mijn selecties